Edition:
United States

Arrowhead Pharmaceuticals Inc (ARWR.PH)

ARWR.PH on Philadelphia Stock Exchange

7.29USD
29 Sep 2016
Change (% chg)

$0.25 (+3.55%)
Prev Close
$7.04
Open
$8.06
Day's High
$8.06
Day's Low
$7.23
Volume
42,965
Avg. Vol
3,552
52-wk High
$8.21
52-wk Low
$3.13

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Douglas Given

63 2013 Chairman of the Board

Christopher Anzalone

46 2007 President, Chief Executive Officer, Director

Kenneth Myszkowski

49 2010 Chief Financial Officer

Bruce Given

61 2011 Chief Operating Officer

David Lewis

52 2013 Chief Scientific Officer